152 related articles for article (PubMed ID: 1277306)
21. PHA skin test-correlation with migration inhibition but not with peripheral blood lymphocytes (PBL) subpopulations. With 1 figure.
Szczylik C; Wiktor-Jedrzejczak W
Allerg Immunol (Leipz); 1981; 27(3):162-7. PubMed ID: 6214937
[TBL] [Abstract][Full Text] [Related]
22. Delayed hypersensitivity to beryllium compounds.
Marx JJ; Burrell R
J Immunol; 1973 Aug; 111(2):590-8. PubMed ID: 4717994
[No Abstract] [Full Text] [Related]
23. [Leukocyte migration inhibition as a method of detecting cellular hypersensitivity in autoimmune diseases].
Traianova TG; Mazharov MK; Rass IT; Sura VV
Ter Arkh; 1973 May; 45(5):49-55. PubMed ID: 4768374
[No Abstract] [Full Text] [Related]
24. [Study of specific allergy in patients with bacillary dysentery by means of the leukocyte migration inhibition test].
Fradkin VA; Lodinova LM; Shchetinina IN
Lab Delo; 1976; (12):731-4. PubMed ID: 63617
[No Abstract] [Full Text] [Related]
25. Human leukocyte migration inhibition as an indicator of cellular hypersensitivity to soluble antigens.
Rauch HC; King K
Int Arch Allergy Appl Immunol; 1973; 44(6):862-74. PubMed ID: 4199134
[No Abstract] [Full Text] [Related]
26. Inflammation-inducing factors from human lymphocytes. Correlation with polymorphonuclear leucocyte migration enhancement of inhibition.
Warrington RJ; Buehler SK; Roberts KB
Int Arch Allergy Appl Immunol; 1976; 51(2):186-97. PubMed ID: 1279021
[TBL] [Abstract][Full Text] [Related]
27. [Detection of hypersensitivity to chromium, cobalt and nickel by means of the leukocyte migration inhibition test].
Czernielewski A; Libiszowski T; Dudek H
Przegl Dermatol; 1978; 65(6):657-60. PubMed ID: 725105
[No Abstract] [Full Text] [Related]
28. [Determining hypersensitivity to antigens by computing cells migrating from capillary tubes].
Novikov DK; Adamenko GP; Novikova VI
Biull Eksp Biol Med; 1976 Jun; 81(6):707-10. PubMed ID: 953309
[TBL] [Abstract][Full Text] [Related]
29. Murine spleen leukocytes as an inhibitable target cell system for human MIF.
Górski AJ
Cell Immunol; 1974 May; 12(2):315-22. PubMed ID: 4617631
[No Abstract] [Full Text] [Related]
30. Correlations between DNCB skin hypersensitivity and leukocyte migration inhibition by DNCB-coated human erythrocytes.
Walewski J; Nowakowska A
Arch Immunol Ther Exp (Warsz); 1981; 29(1):29-33. PubMed ID: 7283677
[TBL] [Abstract][Full Text] [Related]
31. Correlation of PPD and BCG-induced leukocyte migration inhibition, delayed cutaneous hypersensitivity, lymphocyte transformation in vitro and humoral antibodies to PPD in man.
Fleer A; van der Hart M; Blok-Schut BJ; Schellekens PT
Eur J Immunol; 1976 Mar; 6(3):163-7. PubMed ID: 791653
[TBL] [Abstract][Full Text] [Related]
32. [Comparison between results of leukocyte migration inhibition test and skin hypersensitivity of tuberculin in man].
Claudy A; Thivolet J; Valancogne A; Schmitt D
Rev Eur Etud Clin Biol; 1971 Oct; 16(8):826-30. PubMed ID: 5128513
[No Abstract] [Full Text] [Related]
33. [Meaning of leukocyte migration inhibition in the presence of soluble antigens].
Clot J; Mandin J
Ann Inst Pasteur (Paris); 1972 Jul; 123(1):121. PubMed ID: 4640715
[No Abstract] [Full Text] [Related]
34. [PASSIVE TRANSFER OF DELAYED TYPE CUTANEOUS SENSITIVITY TOWARD BACTERIAL CONSTITUENTS (TUBERCULIN, O-STREPTOLYSIN)].
CAGINI P; GENOVA R
Boll Ist Sieroter Milan; 1964; 40():352-7. PubMed ID: 14277939
[No Abstract] [Full Text] [Related]
35. [Our modification of leukocyte migration test and attempt at applying it to the diagnosis of drug allergy].
Chyrek-Borowska S; Sydor A; Sydor U
Pol Arch Med Wewn; 1971 Sep; 47(3):211-6. PubMed ID: 5116353
[No Abstract] [Full Text] [Related]
36. [Correlation between results on intracutaneous, lymphocyte transformation tests and leukocyte migration inhibition tests with tuberculin].
Lischka VG; Bonatz G
Dermatol Monatsschr; 1976 Apr; 162(4):326-32. PubMed ID: 955216
[No Abstract] [Full Text] [Related]
37. [Leukocyte migration inhibition test in syphilis].
Wroński A; Szarmach H
Przegl Dermatol; 1983; 70(3):269-72. PubMed ID: 6665186
[No Abstract] [Full Text] [Related]
38. [Migration inhibitory test and its clinical aspects].
Dobozy A; Hunyadi J; Simon N
Berufsdermatosen; 1973 Aug; 21(4):137-51. PubMed ID: 4583667
[No Abstract] [Full Text] [Related]
39. [Studies on cellular immunity using the leukocyte migration test in dermatoses with various antistreptolysin titres].
Hunyadi J; Dobozy A; Schneider I; Simon N
Arch Dermatol Forsch; 1971; 241(4):385-90. PubMed ID: 5127770
[No Abstract] [Full Text] [Related]
40. Leukocyte migration inhibition assay in hepatoma patients and normal individuals: correlations with skin test.
Lee CS; Jan YY; Lin TY
Taiwan Yi Xue Hui Za Zhi; 1978 Sep; 77(9):661-5. PubMed ID: 214516
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
